Gong Yixin, Wang Qunhua, Chen Suyu, Liu Yujie, Li Chenghua, Kang Rong, Wang Jing, Wei Tian, Wang Qin, Li Xianming, Luo Sihui, Weng Jianping, Zheng Xueying, Ding Yu
Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.
J Clin Endocrinol Metab. 2024 Oct 24. doi: 10.1210/clinem/dgae754.
Diabetes has increasingly been recognized as a heterogeneous disease, with clinical characteristics and outcomes risk varying across different phenotypes. Evidence on heterogeneity of gestational diabetes (GDM) is yet to be provided.
To investigate the insulin physiology and pregnancy outcomes of GDM phenotypes characterized by fasting hyperglycemia or postload hyperglycemia.
A total of 2050 women who underwent a 75-g oral glucose tolerance test were prospectively recruited and followed up until delivery. Women were categorized into normoglycemia (NGT, n = 936), isolated impaired fasting glucose (gestational-IFG, n = 378), and isolated impaired postload glucose tolerance (gestational-IGT, n = 736) groups. Fasting blood sample at mid-pregnancy were collected to measure C-peptide and insulin concentrations. Homeostasis model assessment (HOMA) and quantitative insulin sensitivity check index (QUICKI) were used to evaluate insulin physiology. Maternal and neonatal outcomes were recorded.
Gestational-IFG had greater insulin resistance (HOMA-IR 3.11 vs. 2.25, QUICKI-CP 0.94 vs. 1.03, both P < 0.01), and gestational-IGT had worse β-cell function (C-peptide 2.00 vs. 2.26 ng/ml, P < 0.05) when compared to one another. Gestational-IFG was more strongly associated with excessive gestational weight gain (RR 1.62, 95% CI 1.18-2.23) and large-for-gestational-age infants (RR 1.45, 95% CI 1.03-2.03) than gestational-IGT. The risk for neonatal brain injury was increased in gestational-IGT (RR 2.03, 95% CI 1.04-4.09), but not in gestational-IFG (P = 0.439). Gestational-IGT showed a stronger association with the risk of preterm birth compared to gestational-IFG (RR 1.80, 95% CI 1.02-3.36).
GDM exhibits distinct insulin physiology profiles. Pregnancy outcome varies between each phenotype. These findings provide evidence on risk stratification and diverse strategies for the treatment of GDM.
糖尿病日益被认为是一种异质性疾病,其临床特征和结局风险在不同表型之间存在差异。关于妊娠期糖尿病(GDM)异质性的证据尚未提供。
研究以空腹血糖升高或负荷后血糖升高为特征的GDM表型的胰岛素生理学和妊娠结局。
前瞻性招募了2050名接受75克口服葡萄糖耐量试验的女性,并随访至分娩。将女性分为血糖正常(NGT,n = 936)、单纯空腹血糖受损(妊娠期空腹血糖受损,gestational-IFG,n = 378)和单纯负荷后糖耐量受损(妊娠期糖耐量受损,gestational-IGT,n = 736)组。在妊娠中期采集空腹血样以测量C肽和胰岛素浓度。采用稳态模型评估(HOMA)和定量胰岛素敏感性检查指数(QUICKI)评估胰岛素生理学。记录母婴结局。
与妊娠期糖耐量受损相比,妊娠期空腹血糖受损具有更高的胰岛素抵抗(HOMA-IR 3.11对2.25,QUICKI-CP 0.94对1.03,均P < 0.01),而妊娠期糖耐量受损的β细胞功能更差(C肽2.00对2.26 ng/ml,P < 0.05)。与妊娠期糖耐量受损相比,妊娠期空腹血糖受损与妊娠期体重过度增加(RR 1.62,95%CI 1.18 - 2.23)和大于胎龄儿(RR 1.45,95%CI 1.03 - 2.03)的关联更强。妊娠期糖耐量受损时新生儿脑损伤风险增加(RR 2.03,95%CI 1.04 - 4.09),而妊娠期空腹血糖受损时未增加(P = 0.439)。与妊娠期空腹血糖受损相比,妊娠期糖耐量受损与早产风险的关联更强(RR 1.80,95%CI 1.02 - 3.36)。
GDM表现出不同的胰岛素生理学特征。每种表型的妊娠结局各不相同。这些发现为GDM的风险分层和多样化治疗策略提供了证据。